Stockscreener 앱 받기
54.41
0.09%
0.045
전일 마감가:
$54.36
열려 있는:
$54.35
하루 거래량:
165.94K
Relative Volume:
0.08
시가총액:
$4.48B
수익:
-
순이익/손실:
$-269.44M
주가수익비율:
-14.51
EPS:
-3.75
순현금흐름:
$-262.63M
1주 성능:
+0.09%
1개월 성능:
+0.39%
6개월 성능:
+9.59%
1년 성능:
+69.50%
1일 변동 폭
$54.35
$54.48
1주일 범위
$54.31
$54.48
52주 변동 폭
$21.34
$58.40
Akero Therapeutics Inc Stock (AKRO) Company Profile
명칭
Akero Therapeutics Inc
전화
650-487-6488
주소
601 GATEWAY BOULEVARD, SUITE 350, SOUTH SAN FRANCISCO, CA
AKRO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AKRO
Akero Therapeutics Inc
|
54.41 | 4.47B | 0 | -269.44M | -262.63M | -3.75 |
|
VRTX
Vertex Pharmaceuticals Inc
|
429.85 | 110.02B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
779.10 | 82.00B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.71 | 59.61B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
895.97 | 56.15B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
206.27 | 44.31B | 447.02M | -1.18B | -906.14M | -6.1812 |
Akero Therapeutics Inc Stock (AKRO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-04 | 재개 | H.C. Wainwright | Buy |
| 2025-08-04 | 개시 | TD Cowen | Buy |
| 2025-01-30 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2025-01-27 | 재확인 | H.C. Wainwright | Buy |
| 2024-11-18 | 개시 | Citigroup | Buy |
| 2024-04-22 | 재개 | BofA Securities | Neutral |
| 2023-09-19 | 개시 | Cantor Fitzgerald | Overweight |
| 2023-08-28 | 개시 | UBS | Buy |
| 2023-01-27 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2022-09-14 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2021-10-19 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2021-09-10 | 개시 | BofA Securities | Buy |
| 2021-02-26 | 개시 | Guggenheim | Buy |
| 2020-09-10 | 개시 | Morgan Stanley | Overweight |
| 2020-07-20 | 재확인 | H.C. Wainwright | Buy |
| 2020-07-07 | 개시 | Chardan Capital Markets | Buy |
| 2020-07-01 | 재확인 | H.C. Wainwright | Buy |
| 2020-03-02 | 개시 | H.C. Wainwright | Buy |
| 2020-02-10 | 개시 | Canaccord Genuity | Buy |
| 2019-07-15 | 개시 | Evercore ISI | Outperform |
| 2019-07-15 | 개시 | JP Morgan | Overweight |
| 2019-07-15 | 개시 | Jefferies | Buy |
| 2019-07-15 | 개시 | ROTH Capital | Buy |
모두보기
Akero Therapeutics Inc 주식(AKRO)의 최신 뉴스
Loomis Sayles & Co. L P Acquires 51,850 Shares of Akero Therapeutics, Inc. $AKRO - MarketBeat
SG Americas Securities LLC Sells 1,150,442 Shares of Akero Therapeutics, Inc. $AKRO - MarketBeat
F m Investments LLC Has $960,000 Holdings in Akero Therapeutics, Inc. $AKRO - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Encourages Akero Therapeutics - The National Law Review
Is Akero Therapeutics Inc a good long term investmentMoving Average Strategies & Free High Profit Capital Plays - earlytimes.in
Akero Therapeutics, Inc. (AKRO) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
7,107 Shares in Akero Therapeutics, Inc. $AKRO Bought by DLD Asset Management LP - MarketBeat
Rhenman & Partners Asset Management AB Acquires 105,100 Shares of Akero Therapeutics, Inc. $AKRO - MarketBeat
5,700 Shares in Akero Therapeutics, Inc. $AKRO Bought by North Star Asset Management Inc. - MarketBeat
Akero Therapeutics Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Akero Therapeutics, Inc.AKRO - Business Wire
(AKRO) Movement as an Input in Quant Signal Sets - news.stocktradersdaily.com
Foresite Capital Management VI LLC Has $13.07 Million Stock Holdings in Akero Therapeutics, Inc. $AKRO - MarketBeat
Creative Planning Purchases 25,643 Shares of Akero Therapeutics, Inc. $AKRO - MarketBeat
Ensign Peak Advisors Inc Has $10.05 Million Holdings in Akero Therapeutics, Inc. $AKRO - MarketBeat
What drives Akero Therapeutics Inc 0K4 stock priceAnalyst Upgrades & Fast Growing Stocks - earlytimes.in
Akero Therapeutics, Inc. $AKRO Shares Sold by Geode Capital Management LLC - MarketBeat
Intech Investment Management LLC Sells 16,635 Shares of Akero Therapeutics, Inc. $AKRO - MarketBeat
Will Akero Therapeutics Inc. (0K4) stock outperform value peersPortfolio Profit Report & Daily Oversold Bounce Ideas - newser.com
Halper Sadeh LLC Encourages SEE, AXTA, SEMR, AKRO Shareholders to Contact the Firm to Discuss Their Rights - GlobeNewswire Inc.
What dividend safety rating applies to Akero Therapeutics Inc. (0K4) stockWeekly Investment Report & Free Reliable Trade Execution Plans - newser.com
Is Akero Therapeutics Inc. stock a smart buy before Fed meetingIndex Update & Risk Controlled Daily Trade Plans - newser.com
Is Akero Therapeutics Inc. (0K4) stock a top pick for value investorsPrice Action & Reliable Price Breakout Signals - newser.com
Is Akero Therapeutics Inc. stock a top pick in earnings seasonTreasury Yields & Daily Profit Focused Screening - newser.com
Can Akero Therapeutics Inc. (0K4) stock deliver strong annual returnsMarket Growth Report & Real-Time Volume Analysis - newser.com
Is Akero Therapeutics Inc. (0K4) stock prepared for digital transitionJuly 2025 Setups & Free Weekly Chart Analysis and Trade Guides - newser.com
Is Akero Therapeutics Inc. stock a buy before product launches2025 Dividend Review & Technical Entry and Exit Alerts - newser.com
Why Akero Therapeutics Inc. (0K4) stock attracts HNW investorsJuly 2025 Final Week & Expert Approved Trade Ideas - newser.com
Is Akero Therapeutics Inc. stock attractive for growth ETFsQuarterly Profit Summary & AI Enhanced Trading Signals - newser.com
Why Akero Therapeutics Inc. stock is recommended by analystsQuarterly Trade Review & Short-Term High Return Strategies - newser.com
Is Akero Therapeutics Inc. stock supported by innovation pipelineJuly 2025 Reactions & Free High Accuracy Swing Entry Alerts - newser.com
Is Akero Therapeutics Inc. stock attractive for income investorsProduct Launch & Advanced Technical Signal Analysis - newser.com
Bank of New York Mellon Corp Increases Stake in Akero Therapeutics, Inc. $AKRO - MarketBeat
Heatmap analysis for Akero Therapeutics Inc. and competitors - newser.com
Is Akero Therapeutics Inc. (0K4) stock a contrarian opportunityPortfolio Value Report & Long Hold Capital Preservation Tips - newser.com
Will Akero Therapeutics Inc. stock keep outperforming rivals2025 Market WrapUp & Daily Profit Maximizing Trade Tips - newser.com
What drives Akero Therapeutics Inc stock priceCurrency Fluctuation Impact & Start Building Capital with Zero Risk - earlytimes.in
Akero Therapeutics shares breakthrough MASH treatment data - Traders Union
Akero Therapeutics Inc (AKRO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.22%
자본화:
|
볼륨(24시간):